SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of BioClinica Inc. - BIOC

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of
                     Investors of BioClinica Inc. - BIOC

PR Newswire

NEW YORK, Jan. 30, 2013

NEW YORK, Jan.30, 2013 /PRNewswire/ --Pomerantz Grossman Hufford Dahlstrom &
Gross LLP is investigating claims on behalf of investors of BioClinica Inc.
("BioClinica" or the "Company") (NASDAQ: BIOC) (ISIN: US09071B1008) (CUSIP:
09071B100) concerning the proposed acquisition of BioClinica by JLL Partners,
Inc. in a transaction valued at approximately $123 million in cash.

The investigation concerns whether the BioClinica directors are breaching
their fiduciary duties by failing to adequately shop the Company and maximize
shareholder value. Under the terms of the agreement, BioClinica shareholders
will be entitled to receive $7.25 per share in cash for each share of
BioClinica common stock. However, the price to EBITDA and revenue multiples
are below those of comparable transactions' averages. Moreover, at least one
analyst has set a target price of $9 per share.

BioClinica shareholders seeking more information about this acquisition are
advised to contact Robert Willoughby at rswilloughby@pomlaw.com or
212-661-1100 or 888-476-6529, ext. 237.

The firm is also investigating actions on behalf of shareholders for the
following companies: Arbitron Inc., Net1 Ueps Technologies, Inc., Universal
Technical Institute, Clearwire Corporation, Ameristar Casinos, Inc. K-Swiss,
Inc., Neptune Technologies Bioressources, Inc., Copano Energy LLC., and
Somerset Hills Bancorp.

The Pomerantz Firm, with offices in New York, Chicago and San Diego, is
acknowledged as one of the premier firms in the areas of corporate,
securities, and antitrust class litigation. Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the Pomerantz Firm
pioneered the field of securities class actions. Today, more than 75 years
later, the Pomerantz Firm continues in the tradition he established, fighting
for the rights of the victims of securities fraud, breaches of fiduciary duty,
and corporate misconduct. The Firm has recovered numerous multimillion-dollar
damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.



SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP

Website: http://www.pomerantzlaw.com
Contact: Robert Willoughby, Pomerantz Grossman Hufford Dahlstrom & Gross LLP,
+1-212-661-1100 ext. 237, rswilloughby@pomlaw.com